Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

A gap between the philosophy and the practice of palliative healthcare: sociological perspectives on the practice of nurses in specialised palliative homecare.

Glasdam S, Ekstrand F, Rosberg M, van der Schaaf AM.

Med Health Care Philos. 2019 Aug 5. doi: 10.1007/s11019-019-09918-2. [Epub ahead of print]

PMID:
31385188
2.

High frequency of inactivating tetraspanin C D37 mutations in diffuse large B-cell lymphoma at immune-privileged sites.

Elfrink S, de Winde CM, van den Brand M, Berendsen M, Roemer MGM, Arnold F, Janssen L, van der Schaaf A, Jansen E, Groenen PJTA, Eijkelenboom A, Stevens W, Hess CJ, van Krieken JH, Vermaat JSP, Cleven AHG, de Groen RAL, Neviani V, de Jong D, van Deventer S, Scheijen B, van Spriel AB.

Blood. 2019 Sep 19;134(12):946-950. doi: 10.1182/blood.2019001185. Epub 2019 Jul 31.

PMID:
31366619
3.

External validation of a multifactorial normal tissue complication probability model for tube feeding dependence at 6 months after definitive radiotherapy for head and neck cancer.

Kanayama N, Kierkels RGJ, van der Schaaf A, Steenbakkers RJHM, Yoshioka Y, Nishiyama K, Fujii T, Ogawa K, Langendijk JA, Teshima T.

Radiother Oncol. 2018 Nov;129(2):403-408. doi: 10.1016/j.radonc.2018.09.013. Epub 2018 Oct 6.

PMID:
30301559
4.

C-type lectin-like receptor 2 (CLEC-2)-dependent dendritic cell migration is controlled by tetraspanin CD37.

de Winde CM, Matthews AL, van Deventer S, van der Schaaf A, Tomlinson ND, Jansen E, Eble JA, Nieswandt B, McGettrick HM, Figdor CG, Tomlinson MG, Acton SE, van Spriel AB.

J Cell Sci. 2018 Oct 2;131(19). pii: jcs214551. doi: 10.1242/jcs.214551.

5.

Development of a prediction model for late urinary incontinence, hematuria, pain and voiding frequency among irradiated prostate cancer patients.

Schaake W, van der Schaaf A, van Dijk LV, van den Bergh ACM, Langendijk JA.

PLoS One. 2018 Jul 17;13(7):e0197757. doi: 10.1371/journal.pone.0197757. eCollection 2018.

6.

Clinical Trial Strategies to Compare Protons With Photons.

Langendijk JA, Boersma LJ, Rasch CRN, van Vulpen M, Reitsma JB, van der Schaaf A, Schuit E.

Semin Radiat Oncol. 2018 Apr;28(2):79-87. doi: 10.1016/j.semradonc.2017.11.008. Review.

7.

Interleukin-6 is essential for glomerular immunoglobulin A deposition and the development of renal pathology in Cd37-deficient mice.

Rops ALWMM, Jansen E, van der Schaaf A, Pieterse E, Rother N, Hofstra J, Dijkman HBPM, van de Logt AE, Wetzels J, van der Vlag J, van Spriel AB.

Kidney Int. 2018 Jun;93(6):1356-1366. doi: 10.1016/j.kint.2018.01.005. Epub 2018 Mar 16.

PMID:
29551516
8.

Present developments in reaching an international consensus for a model-based approach to particle beam therapy.

Prayongrat A, Umegaki K, van der Schaaf A, Koong AC, Lin SH, Whitaker T, McNutt T, Matsufuji N, Graves E, Mizuta M, Ogawa K, Date H, Moriwaki K, Ito YM, Kobashi K, Dekura Y, Shimizu S, Shirato H.

J Radiat Res. 2018 Mar 1;59(suppl_1):i72-i76. doi: 10.1093/jrr/rry008.

9.

An automated, quantitative, and case-specific evaluation of deformable image registration in computed tomography images.

Kierkels RGJ, den Otter LA, Korevaar EW, Langendijk JA, van der Schaaf A, Knopf AC, Sijtsema NM.

Phys Med Biol. 2018 Feb 21;63(4):045026. doi: 10.1088/1361-6560/aa9dc2.

PMID:
29182154
10.

Is the coronary artery calcium score associated with acute coronary events in breast cancer patients treated with radiotherapy?

Roos CTG, van den Bogaard VAB, Greuter MJW, Vliegenthart R, Schuit E, Langendijk JA, van der Schaaf A, Crijns APG, Maduro JH.

Radiother Oncol. 2018 Jan;126(1):170-176. doi: 10.1016/j.radonc.2017.10.009. Epub 2017 Oct 28.

PMID:
29089148
11.

Differential expression of tetraspanin superfamily members in dendritic cell subsets.

Zuidscherwoude M, Worah K, van der Schaaf A, Buschow SI, van Spriel AB.

PLoS One. 2017 Sep 7;12(9):e0184317. doi: 10.1371/journal.pone.0184317. eCollection 2017.

12.

Tetraspanin microdomains control localized protein kinase C signaling in B cells.

Zuidscherwoude M, Dunlock VE, van den Bogaart G, van Deventer SJ, van der Schaaf A, van Oostrum J, Goedhart J, In 't Hout J, Hämmerling GJ, Tanaka S, Nadler A, Schultz C, Wright MD, Adjobo-Hermans MJW, van Spriel AB.

Sci Signal. 2017 May 9;10(478). pii: eaag2755. doi: 10.1126/scisignal.aag2755.

PMID:
28487417
13.

Validation and Modification of a Prediction Model for Acute Cardiac Events in Patients With Breast Cancer Treated With Radiotherapy Based on Three-Dimensional Dose Distributions to Cardiac Substructures.

van den Bogaard VA, Ta BD, van der Schaaf A, Bouma AB, Middag AM, Bantema-Joppe EJ, van Dijk LV, van Dijk-Peters FB, Marteijn LA, de Bock GH, Burgerhof JG, Gietema JA, Langendijk JA, Maduro JH, Crijns AP.

J Clin Oncol. 2017 Apr 10;35(11):1171-1178. doi: 10.1200/JCO.2016.69.8480. Epub 2017 Jan 17. Erratum in: J Clin Oncol. 2017 Nov 10;35(32):3736.

14.

Radiation-induced fibrosis in the boost area after three-dimensional conformal radiotherapy with a simultaneous integrated boost technique for early-stage breast cancer: A multivariable prediction model.

Hammer C, Maduro JH, Bantema-Joppe EJ, van der Schaaf A, van der Laan HP, Langendijk JA, Crijns AP.

Radiother Oncol. 2017 Jan;122(1):45-49. doi: 10.1016/j.radonc.2016.10.006. Epub 2016 Oct 25.

PMID:
27793444
15.

Multivariable normal tissue complication probability model-based treatment plan optimization for grade 2-4 dysphagia and tube feeding dependence in head and neck radiotherapy.

Kierkels RGJ, Wopken K, Visser R, Korevaar EW, van der Schaaf A, Bijl HP, Langendijk JA.

Radiother Oncol. 2016 Dec;121(3):374-380. doi: 10.1016/j.radonc.2016.08.016. Epub 2016 Sep 7.

PMID:
27614681
16.

CT image biomarkers to improve patient-specific prediction of radiation-induced xerostomia and sticky saliva.

van Dijk LV, Brouwer CL, van der Schaaf A, Burgerhof JGM, Beukinga RJ, Langendijk JA, Sijtsema NM, Steenbakkers RJHM.

Radiother Oncol. 2017 Feb;122(2):185-191. doi: 10.1016/j.radonc.2016.07.007. Epub 2016 Jul 25.

17.

Selection of head and neck cancer patients for adaptive radiotherapy to decrease xerostomia.

Brouwer CL, Steenbakkers RJ, van der Schaaf A, Sopacua CT, van Dijk LV, Kierkels RG, Bijl HP, Burgerhof JG, Langendijk JA, Sijtsema NM.

Radiother Oncol. 2016 Jul;120(1):36-40. doi: 10.1016/j.radonc.2016.05.025. Epub 2016 Jun 23.

18.

Normal tissue complication probability (NTCP) models for late rectal bleeding, stool frequency and fecal incontinence after radiotherapy in prostate cancer patients.

Schaake W, van der Schaaf A, van Dijk LV, Bongaerts AH, van den Bergh AC, Langendijk JA.

Radiother Oncol. 2016 Jun;119(3):381-7. doi: 10.1016/j.radonc.2016.04.005. Epub 2016 May 3.

PMID:
27157889
19.

Tetraspanin CD37 protects against the development of B cell lymphoma.

de Winde CM, Veenbergen S, Young KH, Xu-Monette ZY, Wang XX, Xia Y, Jabbar KJ, van den Brand M, van der Schaaf A, Elfrink S, van Houdt IS, Gijbels MJ, van de Loo FA, Bennink MB, Hebeda KM, Groenen PJ, van Krieken JH, Figdor CG, van Spriel AB.

J Clin Invest. 2016 Feb;126(2):653-66. doi: 10.1172/JCI81041. Epub 2016 Jan 19.

20.

Swallowing sparing intensity modulated radiotherapy (SW-IMRT) in head and neck cancer: Clinical validation according to the model-based approach.

Christianen ME, van der Schaaf A, van der Laan HP, Verdonck-de Leeuw IM, Doornaert P, Chouvalova O, Steenbakkers RJ, Leemans CR, Oosting SF, van der Laan BF, Roodenburg JL, Slotman BJ, Bijl HP, Langendijk JA.

Radiother Oncol. 2016 Feb;118(2):298-303. doi: 10.1016/j.radonc.2015.11.009. Epub 2015 Dec 14.

21.

The Quest for Evidence for Proton Therapy: Model-Based Approach and Precision Medicine.

Widder J, van der Schaaf A, Lambin P, Marijnen CA, Pignol JP, Rasch CR, Slotman BJ, Verheij M, Langendijk JA.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):30-6. doi: 10.1016/j.ijrobp.2015.10.004. Epub 2015 Oct 9.

PMID:
26684410
22.

Semaphorin 7A Promotes Chemokine-Driven Dendritic Cell Migration.

van Rijn A, Paulis L, te Riet J, Vasaturo A, Reinieren-Beeren I, van der Schaaf A, Kuipers AJ, Schulte LP, Jongbloets BC, Pasterkamp RJ, Figdor CG, van Spriel AB, Buschow SI.

J Immunol. 2016 Jan 1;196(1):459-68. doi: 10.4049/jimmunol.1403096. Epub 2015 Nov 23.

23.

Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer.

van Luijk P, Pringle S, Deasy JO, Moiseenko VV, Faber H, Hovan A, Baanstra M, van der Laan HP, Kierkels RG, van der Schaaf A, Witjes MJ, Schippers JM, Brandenburg S, Langendijk JA, Wu J, Coppes RP.

Sci Transl Med. 2015 Sep 16;7(305):305ra147. doi: 10.1126/scitranslmed.aac4441.

24.

Quantitative comparison of commercial and non-commercial metal artifact reduction techniques in computed tomography.

Wagenaar D, van der Graaf ER, van der Schaaf A, Greuter MJ.

PLoS One. 2015 Jun 1;10(6):e0127932. doi: 10.1371/journal.pone.0127932. eCollection 2015.

25.

Multispectral imaging reveals the tissue distribution of tetraspanins in human lymphoid organs.

de Winde CM, Zuidscherwoude M, Vasaturo A, van der Schaaf A, Figdor CG, van Spriel AB.

Histochem Cell Biol. 2015 Aug;144(2):133-46. doi: 10.1007/s00418-015-1326-2. Epub 2015 May 8.

26.

Relative electron density determination using a physics based parameterization of photon interactions in medical DECT.

van Abbema JK, van Goethem MJ, Greuter MJ, van der Schaaf A, Brandenburg S, van der Graaf ER.

Phys Med Biol. 2015 May 7;60(9):3825-46. doi: 10.1088/0031-9155/60/9/3825. Epub 2015 Apr 23.

PMID:
25905890
27.

Acute symptoms during the course of head and neck radiotherapy or chemoradiation are strong predictors of late dysphagia.

van der Laan HP, Bijl HP, Steenbakkers RJ, van der Schaaf A, Chouvalova O, Vemer-van den Hoek JG, Gawryszuk A, van der Laan BF, Oosting SF, Roodenburg JL, Wopken K, Langendijk JA.

Radiother Oncol. 2015 Apr;115(1):56-62. doi: 10.1016/j.radonc.2015.01.019. Epub 2015 Mar 16.

28.

Embracing phenomenological approaches to normal tissue complication probability modeling: a question of method.

van der Schaaf A, Langendijk JA, Fiorino C, Rancati T.

Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):468-71. doi: 10.1016/j.ijrobp.2014.10.017. Epub 2015 Jan 30. No abstract available. Erratum in: Int J Radiat Oncol Biol Phys. 2015 Jul 1;92(3):702. van der Schaaf, Arjien [corrected to van der Schaaf, Arjen].

PMID:
25680592
29.

Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding dependence after curative radiotherapy/chemo-radiotherapy in head and neck cancer.

Wopken K, Bijl HP, van der Schaaf A, van der Laan HP, Chouvalova O, Steenbakkers RJ, Doornaert P, Slotman BJ, Oosting SF, Christianen ME, van der Laan BF, Roodenburg JL, Leemans CR, Verdonck-de Leeuw IM, Langendijk JA.

Radiother Oncol. 2014 Oct;113(1):95-101. doi: 10.1016/j.radonc.2014.09.013. Epub 2014 Oct 16.

30.

Direct use of multivariable normal tissue complication probability models in treatment plan optimisation for individualised head and neck cancer radiotherapy produces clinically acceptable treatment plans.

Kierkels RG, Korevaar EW, Steenbakkers RJ, Janssen T, van't Veld AA, Langendijk JA, Schilstra C, van der Schaaf A.

Radiother Oncol. 2014 Sep;112(3):430-6. doi: 10.1016/j.radonc.2014.08.020. Epub 2014 Sep 11.

PMID:
25220369
31.

Comparison of acute and subacute genitourinary and gastrointestinal adverse events of radiotherapy for prostate cancer using intensity-modulated radiation therapy, three-dimensional conformal radiation therapy, permanent implant brachytherapy and high-dose-rate brachytherapy.

Morimoto M, Yoshioka Y, Konishi K, Isohashi F, Takahashi Y, Ogata T, Koizumi M, Teshima T, Bijl HP, van der Schaaf A, Langendijk JA, Ogawa K.

Tumori. 2014 May-Jun;100(3):265-71. doi: 10.1700/1578.17198.

PMID:
25076236
32.

Development and validation of a prediction model for tube feeding dependence after curative (chemo-) radiation in head and neck cancer.

Wopken K, Bijl HP, van der Schaaf A, Christianen ME, Chouvalova O, Oosting SF, van der Laan BF, Roodenburg JL, Leemans CR, Slotman BJ, Doornaert P, Steenbakkers RJ, Verdonck-de Leeuw IM, Langendijk JA.

PLoS One. 2014 Apr 15;9(4):e94879. doi: 10.1371/journal.pone.0094879. eCollection 2014.

33.

Role of minor salivary glands in developing patient-rated xerostomia and sticky saliva during day and night.

Beetz I, Schilstra C, Visink A, van der Schaaf A, Bijl HP, van der Laan BF, Steenbakkers RJ, Langendijk JA.

Radiother Oncol. 2013 Nov;109(2):311-6. doi: 10.1016/j.radonc.2013.06.040. Epub 2013 Aug 15.

PMID:
23953752
34.

The tetraspanin CD37 orchestrates the α(4)β(1) integrin-Akt signaling axis and supports long-lived plasma cell survival.

van Spriel AB, de Keijzer S, van der Schaaf A, Gartlan KH, Sofi M, Light A, Linssen PC, Boezeman JB, Zuidscherwoude M, Reinieren-Beeren I, Cambi A, Mackay F, Tarlinton DM, Figdor CG, Wright MD.

Sci Signal. 2012 Nov 13;5(250):ra82. doi: 10.1126/scisignal.2003113.

PMID:
23150881
35.

A phase II study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma.

Nowak AK, Millward MJ, Creaney J, Francis RJ, Dick IM, Hasani A, van der Schaaf A, Segal A, Musk AW, Byrne MJ.

J Thorac Oncol. 2012 Sep;7(9):1449-56. doi: 10.1097/JTO.0b013e31825f22ee.

36.

The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.

van der Laan HP, van de Water TA, van Herpt HE, Christianen ME, Bijl HP, Korevaar EW, Rasch CR, van 't Veld AA, van der Schaaf A, Schilstra C, Langendijk JA; Rococo cooperative group.

Acta Oncol. 2013 Apr;52(3):561-9. doi: 10.3109/0284186X.2012.692885. Epub 2012 Jun 19.

PMID:
22708528
37.

Statistical validation of normal tissue complication probability models.

Xu CJ, van der Schaaf A, Van't Veld AA, Langendijk JA, Schilstra C.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):e123-9. doi: 10.1016/j.ijrobp.2012.02.022. Epub 2012 Apr 27.

PMID:
22541961
38.

NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors.

Beetz I, Schilstra C, van der Schaaf A, van den Heuvel ER, Doornaert P, van Luijk P, Vissink A, van der Laan BF, Leemans CR, Bijl HP, Christianen ME, Steenbakkers RJ, Langendijk JA.

Radiother Oncol. 2012 Oct;105(1):101-6. doi: 10.1016/j.radonc.2012.03.004. Epub 2012 Apr 18.

39.

Preoperative taxane-based chemotherapy in a standardized protocol for locally advanced breast cancer.

Chan A, Willsher PC, Hastrich DJ, Anderson J, Barham T, Latham B, Redfern A, VAN DER Schaaf A, Thomson J, Joseph D, Ingram D.

Asia Pac J Clin Oncol. 2012 Mar;8(1):62-70. doi: 10.1111/j.1743-7563.2011.01489.x. Epub 2012 Jan 12.

PMID:
22369445
40.

Multivariate modeling of complications with data driven variable selection: guarding against overfitting and effects of data set size.

van der Schaaf A, Xu CJ, van Luijk P, Van't Veld AA, Langendijk JA, Schilstra C.

Radiother Oncol. 2012 Oct;105(1):115-21. doi: 10.1016/j.radonc.2011.12.006. Epub 2012 Jan 20.

PMID:
22264894
41.

Impact of statistical learning methods on the predictive power of multivariate normal tissue complication probability models.

Xu CJ, van der Schaaf A, Schilstra C, Langendijk JA, van't Veld AA.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):e677-84. doi: 10.1016/j.ijrobp.2011.09.036. Epub 2012 Jan 13.

PMID:
22245199
42.

Antigen localization controls T cell-mediated tumor immunity.

Zeelenberg IS, van Maren WW, Boissonnas A, Van Hout-Kuijer MA, Den Brok MH, Wagenaars JA, van der Schaaf A, Jansen EJ, Amigorena S, Théry C, Figdor CG, Adema GJ.

J Immunol. 2011 Aug 1;187(3):1281-8. doi: 10.4049/jimmunol.1003905. Epub 2011 Jun 24.

43.

Feasibility and accuracy of tissue characterization with dual source computed tomography.

Van Abbema JK, Van der Schaaf A, Kristanto W, Groen JM, Greuter MJ.

Phys Med. 2012 Jan;28(1):25-32. doi: 10.1016/j.ejmp.2011.01.004. Epub 2011 Feb 18.

PMID:
21333575
44.

A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters.

Nowak AK, Francis RJ, Phillips MJ, Millward MJ, van der Schaaf AA, Boucek J, Musk AW, McCoy MJ, Segal A, Robins P, Byrne MJ.

Clin Cancer Res. 2010 Apr 15;16(8):2409-17. doi: 10.1158/1078-0432.CCR-09-2313. Epub 2010 Apr 6.

45.

The tetraspanin CD37 protects against glomerular IgA deposition and renal pathology.

Rops AL, Figdor CG, van der Schaaf A, Tamboer WP, Bakker MA, Berden JH, Dijkman HB, Steenbergen EJ, van der Vlag J, van Spriel AB.

Am J Pathol. 2010 May;176(5):2188-97. doi: 10.2353/ajpath.2010.090770. Epub 2010 Mar 26.

46.

New precise measurement of the pion weak form factors in pi+-->e+ nugamma decay.

Bychkov M, Pocanić D, Vandevender BA, Baranov VA, Bertl W, Bystritsky YM, Frlez E, Kalinnikov VA, Khomutov NV, Korenchenko AS, Korenchenko SM, Korolija M, Kozlowski T, Kravchuk NP, Kuchinsky NA, Li W, Mekterović D, Mzhavia D, Ritt S, Robmann P, Rondon-Aramayo OA, Rozhdestvensky AM, Sakhelashvili T, Scheu S, Straumann U, Supek I, Tsamalaidze Z, van der Schaaf A, Velicheva EP, Volnykh VP, Wang Y, Wirtz HP.

Phys Rev Lett. 2009 Jul 31;103(5):051802. Epub 2009 Jul 30.

PMID:
19792486
47.

The tetraspanin protein CD37 regulates IgA responses and anti-fungal immunity.

van Spriel AB, Sofi M, Gartlan KH, van der Schaaf A, Verschueren I, Torensma R, Raymakers RA, Loveland BE, Netea MG, Adema GJ, Wright MD, Figdor CG.

PLoS Pathog. 2009 Mar;5(3):e1000338. doi: 10.1371/journal.ppat.1000338. Epub 2009 Mar 13.

48.

Functional diffusion tensor imaging: measuring task-related fractional anisotropy changes in the human brain along white matter tracts.

Mandl RC, Schnack HG, Zwiers MP, van der Schaaf A, Kahn RS, Hulshoff Pol HE.

PLoS One. 2008;3(11):e3631. doi: 10.1371/journal.pone.0003631. Epub 2008 Nov 4.

49.

Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans.

Francis RJ, Byrne MJ, van der Schaaf AA, Boucek JA, Nowak AK, Phillips M, Price R, Patrikeos AP, Musk AW, Millward MJ.

J Nucl Med. 2007 Sep;48(9):1449-58. Epub 2007 Aug 17.

50.

Supplemental Content

Loading ...
Support Center